National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 452339

History of Changes from the VAERS Wayback Machine

First Appeared on 6/13/2012

VAERS ID: 452339
Age:12.0
Gender:Female
Location:Foreign
Vaccinated:2010-06-23
Onset:2010-07-26
Submitted:2012-03-22
Entered:2012-03-23
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. NJ51180 / 1 UN / IM
MMR: MEASLES + MUMPS + RUBELLA (PRIORIX) / GLAXOSMITHKLINE BIOLOGICALS A69CC192A / 1 UN / SC

Administered by: Unknown      Purchased by: Unknown
Symptoms: Type 1 diabetes mellitus

Life Threatening? No
Died? No
Permanent Disability? Yes
Recovered? No
ER or Doctor Visit? No
Hospitalized? Yes, days:     Extended hospital stay? No
Previous Vaccinations:
Other Medications: Unknown
Current Illness:
Preexisting Conditions: Unknown
Diagnostic Lab Data: Unknown
CDC 'Split Type': WAES1203USA01785

Write-up:Case received from Health Authority (case n. 160894) through SPMSD (local case n. IT127/12). Initial report received from a physician on 12-MAR-2012. Case medically confirmed. A 12 year old female patient was vaccinated on 23-JUN-2010 with the second dose of GARDASIL (batch number reported as: NM18240, lot number: NJ51180) IM (dose was not reported), the patient had also been vaccinated on 20-MAY-2010 with the second dose of PRIORIX (Mfr. GSK, batch n A69CC192A), SC. On 26-JUL-2010 she was diagnosed with Type I diabetes mellitus, she was hospitalized and started on insulin therapy. At the time of reporting she had not recovered. The final outcome was not reported. Upon internal review the company judged relevant to and seriousness criteria hospitalization which was mentioned by the HA in the narrative. The case is closed. The event was also reported to be disabling. The other business partner numbers include E2012-01720.


Changed on 6/14/2014

VAERS ID: 452339 Before After
Age:12.0
Gender:Female
Location:Foreign
Vaccinated:2010-06-23
Onset:2010-07-26
Submitted:2012-03-22
Entered:2012-03-23
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. NJ51180 / 1 UN / IM
MMR: MEASLES + MUMPS + RUBELLA (PRIORIX) / GLAXOSMITHKLINE BIOLOGICALS A69CC192A / 1 UN / SC

Administered by: Unknown      Purchased by: Unknown
Symptoms: Type 1 diabetes mellitus

Life Threatening? No
Died? No
Permanent Disability? Yes
Recovered? No
ER or Doctor Visit? No
Hospitalized? Yes, days:     Extended hospital stay? No
Previous Vaccinations:
Other Medications: Unknown
Current Illness:
Preexisting Conditions: Unknown
Diagnostic Lab Data: Unknown
CDC 'Split Type': WAES1203USA01785

Write-up:Case received from Health Authority (case n. 160894) through SPMSD (local case n. IT127/12). Initial report received from a physician on 12-MAR-2012. Case medically confirmed. A 12 year old female patient was vaccinated on 23-JUN-2010 with the second dose of GARDASIL (batch number reported as: NM18240, lot number: NJ51180) IM (dose was not reported), the patient had also been vaccinated on 20-MAY-2010 with the second dose of PRIORIX (Mfr. GSK, batch n A69CC192A), SC. On 26-JUL-2010 she was diagnosed with Type I diabetes mellitus, she was hospitalized and started on insulin therapy. At the time of reporting she had not recovered. The final outcome was not reported. Upon internal review the company judged relevant to and seriousness criteria hospitalization which was mentioned by the HA in the narrative. The case is closed. The event was also reported to be disabling. The other business partner numbers include E2012-01720.


Changed on 4/14/2017

VAERS ID: 452339 Before After
Age:12.0
Gender:Female
Location:Foreign
Vaccinated:2010-06-23
Onset:2010-07-26
Submitted:2012-03-22
Entered:2012-03-23
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. NJ51180 / 1 UN / IM
MMR: MEASLES + MUMPS + RUBELLA (PRIORIX) / GLAXOSMITHKLINE BIOLOGICALS A69CC192A / 1 UN / SC

Administered by: Unknown      Purchased by: Unknown
Symptoms: Type 1 diabetes mellitus

Life Threatening? No
Died? No
Permanent Disability? Yes
Recovered? No
ER or Doctor Visit? No
Hospitalized? Yes, days:     Extended hospital stay? No
Previous Vaccinations:
Other Medications: Unknown
Current Illness:
Preexisting Conditions: Unknown
Diagnostic Lab Data: Unknown
CDC 'Split Type': WAES1203USA01785

Write-up:Case received from Health Authority (case n. 160894) through SPMSD (local case n. IT127/12). Initial report received from a physician on 12-MAR-2012. Case medically confirmed. A 12 year old female patient was vaccinated on 23-JUN-2010 with the second dose of GARDASIL (batch number reported as: NM18240, lot number: NJ51180) IM (dose was not reported), the patient had also been vaccinated on 20-MAY-2010 with the second dose of PRIORIX (Mfr. GSK, batch n A69CC192A), SC. On 26-JUL-2010 she was diagnosed with Type I diabetes mellitus, she was hospitalized and started on insulin therapy. At the time of reporting she had not recovered. The final outcome was not reported. Upon internal review the company judged relevant to and seriousness criteria hospitalization which was mentioned by the HA in the narrative. The case is closed. The event was also reported to be disabling. The other business partner numbers include E2012-01720.


New Search

Link To This Search Result:

http://www.medalerts.org/vaersdb/findfield.php?IDNUMBER=452339&WAYBACKHISTORY=ON


Copyright © 2017 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166